Brief: IMC Announces Potential Reverse Merger with Kadimastem
28/02/2024 14:17
Feb 28 (Reuters) - IM Cannabis Corp IMCC.CD :
* IMC ANNOUNCES POTENTIAL REVERSE MERGER WITH KADIMASTEM A
LEADING
CLINICAL CELL THERAPY COMPANY
* IM CANNABIS : KADIMASTEM SHAREHOLDERS WILL HOLD 88% OF
COMMON
SHARES OF RESULTING ISSUER, SHAREHOLDERS OF CO WILL HOLD 12%
Source text for Eikon: ID:nCNWtxmnna
Further company coverage: IMCC.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IM Cannabis
See all newsBrief: IM Cannabis Provides Corporate Updates
Brief: IM Cannabis Announces Appointment Of Shmulik Arbel To Board Of Directors
IM Cannabis Corp reports results for the quarter ended in June - Earnings Summary
Brief: IMCC Addresses Accelerated Growth in Germany Through new Supply Agreement with EU-GMP Certified Glasshouse Botanics and Announces a Change to its Board of Directors
Brief: Avant And IMC Execute BLK MKT Trademark Licensing Agreement For The German Medical Cannabis Market